J&J Acquires Phase III Antibiotic Via Peninsula Purchase

Johnson & Johnson is acquiring the Phase III injectable carbapenem antibiotic doripenem via the $245 mil. acquisition of Peninsula Pharmaceuticals

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet